Kate Rochlin

Company: IN8bio

Job title: Chief Operating Officer

Seminars:

Panel Discussion: What Needs to be Done to Fully Capitalize on the Promise of Genetic Engineering to Produce Scalable & Clinically Efficacious Gamma Delta T Cells? 4:15 pm

Debating the need for genetic engineering to enable strong clinical results Comparing and contrasting the need for CARs or other types of gene engineering to enhance efficacy Leveraging different engineering technologies to equip gamma delta Ts with the genetic capabilities to maximize persistenceRead more

day: Conference Day One